Rodig et al. identified 20 (5.6 %) ALK rearrangements patients in 358 lung adenocarcinomas and found ALK rearrangements to be associated with younger age (p = 0.0002), never smoking (p < 0.0001) (Rodig et al. 2009). This evidence concerns the gene ALK and lung adenocarcinoma.